Tim Watkins - CMO & Head of Development at Contineum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CMO & Head of Development
Issuer Symbol
CTNM on Nasdaq
All Insider Reports
All Insider Reports

Tim Watkins - trading volume in the past year for Contineum Therapeutics, Inc.

Holdings reported by Tim Watkins for Contineum Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 0 $0 $12.06 29 Dec 2025 Direct
Stock Option (right to buy) 256,389 29 Dec 2025 Direct Class A Common Stock

Transactions reported by Tim Watkins for Contineum Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.